Latest News - Pharm Tech Europe
  • Subscribe / Renew
  • E-directory
  • Past Issues
  • About Us
  • Contact Us
  • Sign Up: e-Newsletter
 

ADVERTISEMENT

May 17, 2008

Latest News
  • Advancing respiratory drug development


    An agreement between GE Healthcare and Merck & Co. to share technology on imaging in the lungs could help respiratory treatment development.

    A potent treatment for autoimmune diseases


    An old therapy for a variety of autoimmune diseases is to be made more efficient thanks to 10 years of research.

    Europe and India seek improved safety


    A collaboration between Europe and India will strengthen efforts to improve the quality and safety of medicines in both locations, and will include the development of joint inspections of manufacturing sites.

    Can tomatoes stop us from ageing?


    Tomatoes could be the new weapon in the fight against sun damage, according to research conducted by two UK universities.

    British university research under threat


    Pharma's extensive collaborative research links with the UK university science base are now under threat because of costs and issues regarding intellectual property ownership.

    An end to exchange rate concerns?


    Pharmaceutical companies are being offered the opportunity to purchase foreign currency up to 12 months before the money has to change hands, which could remove concerns regarding fluctuations in the currency market.

    New research area to provide new treatments?


    Research into the link between allergies and the development of tumours has become an established research discipline that could have benefits for future cancer treatments.

    Has pharma run out of treatments?


    Doctors are running out of treatments for trauma victims and critically ill patients because of infections from drug-resistant microbes, according to a speaker at the Society for General Microbiology's recent meeting in Edinburgh (UK).

    Reddy-ly entering Europe


    Two new European acquisitions will enhance Indian-based Dr Reddy?s generic pipeline and R&D infrastructure, which could lead to an increased number of cheaper medicines for patients.

Make This Page Your Home Page!
Subscribe to Pharmaceutical Technologist online mag now!
More details...
Boost your marketing campaigns
RECEIVE THE WEEKLY E-ALERT
Register for the
weekly PTE e-alert
Click here